Oncologists Accepting Cigna in Boston, MAPage 5

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Craig Bunnell, MD

Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on

Oncology

Justine Cohen, DO

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Esther Rhei, MD

Medical Director, Comprehensive Breast Health Center

Oncology

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

Omar Nadeem, M.D.

Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Ephraim Hochberg, MD

Oncology

Matthew Mossanen, M.D.

Faculty Member, Division of Urological Surgery

Oncology

Anthony Damico, MD

Chief, Division of Genitourinary Radiation Oncology; Professor of Radiation Oncology, Harvard Medical School

Oncology

Richard Penson, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Medical Gynecologic Oncology, Massachusetts General Hospital

Oncology

Joel Goldberg, MD

Assistant Professor of Surgery, Harvard Medical School; Chief Resident, Surgery

Oncology

Elad Sharon, M.D.

Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha

Oncology

Thomas Clancy, MD

Director, Pancreas and Biliary Tumor Center; Director, Program in Pancreatic Cancer, Division of Surgical Oncology, Brigham and Women’s Hospital

Oncology

Wenxin Xu, M.D.

Instructor in Medicine, Genitourinary Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Oncology

William Hahn, MD PHD

Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.

Oncology

Leah Biller, MD

Assistant Professor of Medicine at Harvard Medical School and a physician in the Gastrointestinal Cancer Center and the Cancer Genetics and Prevention Center at Dana-Far

Oncology

Paul Mathew, M.D.

Associate Professor, Medical Oncology, Tufts University School of Medicine

Oncology

Ross Berkowitz, MD

Professor of Gynecology, Harvard Medical School

Oncology